Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chun FK et al. – Prostate cancer gene 3 (PCA3) represents a novel marker that is capable of increasing the accuracy of multivariable biopsy models. The authors suggest the use of our PCA3–based nomogram, which better identifies people at risk of harboring prostate cancer, to assist clinicians in deciding whether further evaluation is necessary.

Related Articles

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09    Relevance Score: 72%

Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection
The Journal of Urology, 11/13/09    Relevance Score: 71%

A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09    Relevance Score: 71%

Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09    Relevance Score: 71%

Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09    Relevance Score: 71%

Today in Basic Science/Genetics...keeping you current

Analysis of Polymorphisms in the SRD5A2 Gene and Semen Parameters in Estonian Men
Journal of Andrology, 11/24/09

CD10 expression in urothelial carcinoma of the bladder
Diagnostic Pathology, 11/23/09

Increased Prevalance of the -211 T Allele of Follicle Stimulating Hormone (FSH)beta Subunit Promoter Polymorphism and Lower Serum FSH in Infertile Men
Journal of Clinical Endocrinology and Metabolism, 11/23/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address